35 related articles for article (PubMed ID: 33466191)
1. Identification of Biological Targets of Therapeutic Intervention for Hepatocellular Carcinoma by Integrated Bioinformatical Analysis.
Hu WQ; Wang W; Fang DL; Yin XF
Med Sci Monit; 2018 May; 24():3450-3461. PubMed ID: 29795057
[TBL] [Abstract][Full Text] [Related]
2. Single-Cell Sequencing of Hepatocellular Carcinoma Reveals Cell Interactions and Cell Heterogeneity in the Microenvironment.
Li X; Wang L; Wang L; Feng Z; Peng C
Int J Gen Med; 2021; 14():10141-10153. PubMed ID: 34992435
[TBL] [Abstract][Full Text] [Related]
3. Role of CENPF and NDC80 in the rehabilitation nursing of hepatocellular carcinoma and cirrhosis: An observational study.
Jia W; Wu Q; Li R; Hou S; Kang C
Medicine (Baltimore); 2024 May; 103(18):e37984. PubMed ID: 38701255
[TBL] [Abstract][Full Text] [Related]
4. Potential biomarkers of HCC based on gene expression and DNA methylation profiles.
Meng C; Shen X; Jiang W
Oncol Lett; 2018 Sep; 16(3):3183-3192. PubMed ID: 30127913
[TBL] [Abstract][Full Text] [Related]
5. Prediction of interactomic hub genes in PBMC cells in type 2 diabetes mellitus, dyslipidemia, and periodontitis.
Yadalam PK; Arumuganainar D; Ronsivalle V; Di Blasio M; Badnjevic A; Marrapodi MM; Cervino G; Minervini G
BMC Oral Health; 2024 Mar; 24(1):385. PubMed ID: 38532421
[TBL] [Abstract][Full Text] [Related]
6. Hub gene identification and immune infiltration analysis in hepatocellular carcinoma: Computational approach.
Pulakuntla S; Singh SA; Reddy VD
In Silico Pharmacol; 2024; 12(1):39. PubMed ID: 38721057
[TBL] [Abstract][Full Text] [Related]
7. Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma.
Hong J; Eun JW; Baek GO; Cheong JY; Park S; Kim SS; Cho HJ; Lim SB
Clin Mol Hepatol; 2024 Mar; ():. PubMed ID: 38486508
[TBL] [Abstract][Full Text] [Related]
8. Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers.
Janysek DC; Kim J; Duijf PHG; Dray E
Transl Oncol; 2021 Mar; 14(3):101012. PubMed ID: 33516088
[TBL] [Abstract][Full Text] [Related]
9. Undifferentiated large cell/rhabdoid carcinoma presenting in the intestines of patients with concurrent or recent non-small cell lung cancer (NSCLC): clinicopathologic and molecular analysis of 14 cases indicates an unusual pattern of dedifferentiated metastases.
Agaimy A; Daum O; Michal M; Schmidt MW; Stoehr R; Hartmann A; Lauwers GY
Virchows Arch; 2021 Jul; 479(1):157-167. PubMed ID: 33506327
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma.
Deng X; Bi Q; Chen S; Chen X; Li S; Zhong Z; Guo W; Li X; Deng Y; Yang Y
Front Mol Biosci; 2020; 7():611626. PubMed ID: 33505990
[TBL] [Abstract][Full Text] [Related]
11. Identification of the hub gene BUB1B in hepatocellular carcinoma via bioinformatic analysis and in vitro experiments.
Fu J; Zhang X; Yan L; Shao Y; Liu X; Chu Y; Xu G; Xu X
PeerJ; 2021; 9():e10943. PubMed ID: 33665036
[TBL] [Abstract][Full Text] [Related]
12. Identification of hub genes and biological pathways in hepatocellular carcinoma by integrated bioinformatics analysis.
Zhao Q; Zhang Y; Shao S; Sun Y; Lin Z
PeerJ; 2021; 9():e10594. PubMed ID: 33552715
[TBL] [Abstract][Full Text] [Related]
13. Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma.
Heinrich B; Ruf B; Subramanyam V; Myojin Y; Lai CW; Craig AJ; Fu J; Xie C; Kroemer A; Greten TF; Korangy F
Front Immunol; 2022; 13():849958. PubMed ID: 35833139
[TBL] [Abstract][Full Text] [Related]
14. RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma.
Han Z; Feng W; Hu R; Ge Q; Ma W; Zhang W; Xu S; Zhan B; Zhang L; Sun X; Zhou X
Sci Rep; 2021 Sep; 11(1):17797. PubMed ID: 34493740
[TBL] [Abstract][Full Text] [Related]
15. Predictive three-biomarker panel in peripheral blood mononuclear cells for detecting hepatocellular carcinoma.
Fayazzadeh S; Ghorbaninejad M; Rabbani A; Zahiri J; Meyfour A
Sci Rep; 2024 Mar; 14(1):7527. PubMed ID: 38553531
[TBL] [Abstract][Full Text] [Related]
16. Increased
Gao C; Shen J; Chen W; Yao L; Liang X; Zhu R; Chen Z
J Gastrointest Oncol; 2021 Aug; 12(4):1905-1926. PubMed ID: 34532138
[TBL] [Abstract][Full Text] [Related]
17. The expression and prognostic value of REXO4 in hepatocellular carcinoma.
Chen W; Gao C; Shen J; Yao L; Liang X; Chen Z
J Gastrointest Oncol; 2021 Aug; 12(4):1704-1717. PubMed ID: 34532121
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis.
Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
Medicine (Baltimore); 2021 Jan; 100(2):e24172. PubMed ID: 33466191
[TBL] [Abstract][Full Text] [Related]
19. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
